These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 32463473)
21. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. Wei XC; Xia YR; Zhou P; Xue X; Ding S; Liu LJ; Zhu F World J Gastroenterol; 2021 Dec; 27(48):8302-8322. PubMed ID: 35068871 [TBL] [Abstract][Full Text] [Related]
22. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma. Ren K; Li T; Zhang W; Ren J; Li Z; Wu G J Biomed Sci; 2016 Nov; 23(1):79. PubMed ID: 27832779 [TBL] [Abstract][Full Text] [Related]
23. Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma. Zeng C; Yuan G; Hu Y; Wang D; Shi X; Zhu D; Hu A; Meng Y; Lu J Bioengineered; 2022 Jan; 13(1):1491-1506. PubMed ID: 34986757 [TBL] [Abstract][Full Text] [Related]
24. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549. Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669 [TBL] [Abstract][Full Text] [Related]
25. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis. Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833 [TBL] [Abstract][Full Text] [Related]
26. Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma. Liu W; Zheng L; Zhang R; Hou P; Wang J; Wu L; Li J Mol Cancer; 2022 Mar; 21(1):72. PubMed ID: 35277182 [TBL] [Abstract][Full Text] [Related]
27. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Varshney A; Panda JJ; Singh AK; Yadav N; Bihari C; Biswas S; Sarin SK; Chauhan VS Hepatology; 2018 Apr; 67(4):1392-1407. PubMed ID: 29108133 [TBL] [Abstract][Full Text] [Related]
28. MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway. Yang Y; Yang Z; Zhang R; Jia C; Mao R; Mahati S; Zhang Y; Wu G; Sun YN; Jia XY; Aimudula A; Zhang H; Bao Y Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34096570 [TBL] [Abstract][Full Text] [Related]
29. Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7. Pan X; Shi X; Zhang H; Chen Y; Zhou J; Shen F; Wang J; Jiang R Gene; 2024 Nov; 927():148738. PubMed ID: 38955306 [TBL] [Abstract][Full Text] [Related]
30. Exosomal MiR-500a-3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer. Lin H; Zhang L; Zhang C; Liu P J Cell Mol Med; 2020 Aug; 24(16):8930-8941. PubMed ID: 32588541 [TBL] [Abstract][Full Text] [Related]
31. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer. Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859 [TBL] [Abstract][Full Text] [Related]
32. miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG. Chen S; Yang C; Sun C; Sun Y; Yang Z; Cheng S; Zhuge B DNA Cell Biol; 2019 Aug; 38(8):865-873. PubMed ID: 31225740 [TBL] [Abstract][Full Text] [Related]
33. Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p. Wang X; Zhang Y; Li W; Liu X J Surg Res; 2021 May; 261():185-195. PubMed ID: 33444948 [TBL] [Abstract][Full Text] [Related]
34. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Henry JC; Park JK; Jiang J; Kim JH; Nagorney DM; Roberts LR; Banerjee S; Schmittgen TD Biochem Biophys Res Commun; 2010 Dec; 403(1):120-5. PubMed ID: 21055388 [TBL] [Abstract][Full Text] [Related]
35. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines. Zhuo L; Liu J; Wang B; Gao M; Huang A Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111 [TBL] [Abstract][Full Text] [Related]
36. Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway. Zhou Y; Tang W; Zhuo H; Zhu D; Rong D; Sun J; Song J Bioengineered; 2022 Mar; 13(3):4786-4797. PubMed ID: 35139763 [TBL] [Abstract][Full Text] [Related]
37. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis. Jin J; Liu H; Jin M; Li W; Xu H; Wei F Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866 [TBL] [Abstract][Full Text] [Related]
38. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545 [TBL] [Abstract][Full Text] [Related]
39. Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation. Li W; Qiu Y; Hao J; Zhao C; Deng X; Shu G Food Chem Toxicol; 2018 Nov; 121():156-165. PubMed ID: 30171973 [TBL] [Abstract][Full Text] [Related]
40. Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy. Ma Y; Yuwen D; Chen J; Zheng B; Gao J; Fan M; Xue W; Wang Y; Li W; Shu Y; Xu Q; Shen Y Int J Nanomedicine; 2019; 14():8121-8132. PubMed ID: 31632022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]